TODRALAZINE HYDROCHLORIDE ANHYDROUS
UNII C59540FEXP

Substance Identification & Data

This profile provides standardized clinical and technical data for Todralazine Hydrochloride Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C59540FEXP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3778-76-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

C59540FEXP

CAS Registry Number

3778-76-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TODRALAZINE HYDROCHLORIDE ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C11H12N4O2.ClH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

OMCOKCNIYWULQH-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C218372

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

19604

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

CCOC(=O)NNc1nncc2ccccc21.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Todralazine Hydrochloride Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.